Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine

J Antimicrob Chemother. 2024 Oct 1;79(10):2720-2724. doi: 10.1093/jac/dkae257.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents* / administration & dosage
  • Anti-HIV Agents* / therapeutic use
  • Diketopiperazines
  • Drug Monitoring
  • Female
  • HIV Infections* / drug therapy
  • HIV Infections* / virology
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Pyridones* / administration & dosage
  • Rilpivirine* / administration & dosage
  • Rilpivirine* / therapeutic use
  • Viral Load / drug effects

Substances

  • Rilpivirine
  • cabotegravir
  • Pyridones
  • Anti-HIV Agents
  • Diketopiperazines